June 15. 2020

This is a follow up to the May 21, 2020 article "U.S. President Donald Trump Is Taking The Drug Hydroxychloroquine" where I stated, "U.S. President, Donald Trump, has been taking the anti-malaria drug, Hydroxychloroquine, as a preventative measure against the deadly coronavirus (Covid-19). I do not think it is safe for the president or anyone else to take Hydroxychloroquine as a preventative measure."

I labeled the drug Hydroxychloroquine a last resort, preferring oxygen and vitamin C immuno styled therapy, as stated in May 27, 2020 article "Woman Who Took The Medicine Hydroxychloroquine For 20-Years Still Contracted Coronavirus (Covid-19)."

A large infusion of vitamin C has worked in China and New York hospitals and is permitted under the laws of each nation in controlled, hospital and licensed clinical settings [China And New York Hospitals Using Vitamin C To Aid In Treating Coronavirus Patients (Confirming Previous Claims)].

In the aforementioned May 27, 2020 article I stated, "I think oxygen and immuno styled therapies, with the goal of strengthening the immune system to aid it in fighting the virus, are a positive way to treat coronavirus [China And New York Hospitals Using Vitamin C To Aid In Treating Coronavirus Patients (Confirming Previous Claims)]. Doctors have experienced success with plasma based therapies as well, which is an old and effective medical and scientific concept (which is introducing Covid-19 antibodies from survivors who successfully recovered, into the bodies coronavirus sufferers struggling with the virus and at risk of dying)."

Today, the U.S. Food and Drug Administration (FDA) has officially revoked the use of the pharmaceutical medicine Hydroxychloroquine for emergency use in treating the deadly coronavirus outbreak (Covid-19). The FDA cited the negative cardiac side effects that accompanies the use of the drug.

U.S. president, Donald Trump, has been taking the drug as a preventative measure against the coronavirus. However, it has not been proven to prevent the development of coronavirus and poses a risk to his cardiac health. He should desist taking the drug as a preventative measure.

STORY SOURCE

FDA revokes emergency use of hydroxychloroquine for COVID-19

The FDA cites recent data showing hydroxychloroquine and chloroquine offer no benefits for coronavirus patients.
An anti-malaria drug President Donald Trump touted as a treatment for COVID-19 has taken another hit, this time from the US Food and Drug Administration. A letter from FDA chief scientist Denise Hinton on Monday announced the agency is revoking the emergency use of oral formulations of hydroxychloroquine and chloroquine for treatment of the disease cause by the coronavirus.

The FDA in April cautioned against the use of hydroxychloroquine or chloroquine for COVID-19 outside of a hospital setting or clinical trial. The new directive is a more definitive closing of the door on its use for treating coronavirus patients.
The letter was in response to a request from Gary Disbrow, acting director of the Biomedical Advanced Research and Development Authority (BARDA), a government group charged with developing countermeasures for medical threats, including pandemics...

https://www.cnet.com

Overnight Health Care: FDA withdraws emergency use authorization for hydroxychloroquine | Surging coronavirus cases raise fears of new lockdowns | Trump on coronavirus: 'If we stop testing right now, we'd have very few cases, if any'

06/15/20 06:27 PM EDT - There are now more than 2 million COVID-19 infections in the U.S., according to Johns Hopkins University. More than 116,000 people have died. The FDA revoked the emergency authorization for chloroquine and hydroxychloroquine, President Trump's favored coronavirus treatments.

Cases are surging in states across the country, but Trump and Vice President Pence said the rise is due to increased testing. They continue to push states to reopen their economies, quickly, despite the spikes.

The Food and Drug Administration (FDA) has withdrawn the emergency use authorization for chloroquine and hydroxychloroquine, two drugs promoted by President Trump to treat COVID-19, because of serious safety issues.

According to FDA, recent clinical trial failures mean the drugs may not be effective at treating COVID-19 or preventing it in people who have been exposed, and that their potential benefits do not outweigh the risks. FDA noted that the request to remove the authorization was an “interagency effort” prompted by new clinical trial results and other information...

https://thehill.com